Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guo-Ming Shi

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
Cancer Research|August 2, 2018
Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic InsultYuxiao Yao, Shaoyang Sun, Jingjing Wang, et al.
International Journal of Cancer|May 16, 2019
HNRNPAB-regulated lncRNA-ELF209 inhibits the malignancy of hepatocellular carcinomaYi Yang, Qing Chen, Hai-Yan Piao, et al.
Plos One|May 2, 2013
Genetic polymorphism of the kinesin-like protein KIF1B gene and the risk of hepatocellular carcinomaZhi-Chao Wang, Qiang Gao, Jie-Yi Shi, et al.
Journal of Hematology & Oncology|February 28, 2018
NOD-like receptor X1 functions as a tumor suppressor by inhibiting epithelial-mesenchymal transition and inducing aging in hepatocellular carcinoma cellsBo Hu, Guang-Yu Ding, Pei-Yao Fu, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|November 8, 2020
Do the existing staging systems for primary liver cancer apply to combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma?Qiang Zhou, Hao Cai, Ming-Hao Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2011
Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulationZhen-Bin Ding, Bo Hui, Ying-Hong Shi, et al.
Journal of Oncology|November 21, 2022
Effectiveness and Safety of Avatrombopag in Liver Cancer Patients with Severe Thrombocytopenia: Real-World Data and ChallengesAo Huang, Jia-Feng Chen, Jian-Zhang Wu, et al.
American Journal of Cancer Research|July 24, 2018
Invasive potential of hepatocellular carcinoma is enhanced by loss of selenium-binding protein 1 and subsequent upregulation of CXCR4Ping-Ting Gao, Guang-Yu Ding, Xuan Yang, et al.
Molecular Cancer|June 3, 2019
Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progressionPeng-Fei Zhang, Chuan-Yuan Wei, Xiao-Yong Huang, et al.
International Journal of Oncology|November 15, 2016
Lamp2a is required for tumor growth and promotes tumor recurrence of hepatocellular carcinomaZhen-Bin Ding, Xiu-Tao Fu, Ying-Hong Shi, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Cancer Research|August 2, 2018
Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic InsultYuxiao Yao, Shaoyang Sun, Jingjing Wang, et al.
International Journal of Cancer|May 16, 2019
HNRNPAB-regulated lncRNA-ELF209 inhibits the malignancy of hepatocellular carcinomaYi Yang, Qing Chen, Hai-Yan Piao, et al.
Plos One|May 2, 2013
Genetic polymorphism of the kinesin-like protein KIF1B gene and the risk of hepatocellular carcinomaZhi-Chao Wang, Qiang Gao, Jie-Yi Shi, et al.
Journal of Hematology & Oncology|February 28, 2018
NOD-like receptor X1 functions as a tumor suppressor by inhibiting epithelial-mesenchymal transition and inducing aging in hepatocellular carcinoma cellsBo Hu, Guang-Yu Ding, Pei-Yao Fu, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|November 8, 2020
Do the existing staging systems for primary liver cancer apply to combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma?Qiang Zhou, Hao Cai, Ming-Hao Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2011
Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulationZhen-Bin Ding, Bo Hui, Ying-Hong Shi, et al.
Journal of Oncology|November 21, 2022
Effectiveness and Safety of Avatrombopag in Liver Cancer Patients with Severe Thrombocytopenia: Real-World Data and ChallengesAo Huang, Jia-Feng Chen, Jian-Zhang Wu, et al.
American Journal of Cancer Research|July 24, 2018
Invasive potential of hepatocellular carcinoma is enhanced by loss of selenium-binding protein 1 and subsequent upregulation of CXCR4Ping-Ting Gao, Guang-Yu Ding, Xuan Yang, et al.
Molecular Cancer|June 3, 2019
Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progressionPeng-Fei Zhang, Chuan-Yuan Wei, Xiao-Yong Huang, et al.
International Journal of Oncology|November 15, 2016
Lamp2a is required for tumor growth and promotes tumor recurrence of hepatocellular carcinomaZhen-Bin Ding, Xiu-Tao Fu, Ying-Hong Shi, et al.
Pageof 10